Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Home Away From Home - Medical Outcomes

ClinicalTrials.gov ID: NCT02774850

Public ClinicalTrials.gov record NCT02774850. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 4:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Home or Away From Home: Comparing Clinical Outcomes Relevant to the Care of Pediatric Acute Myeloid Leukemia During Periods of Neutropenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Treatment for pediatric acute myeloid leukemia (AML) involves intensive chemotherapy regimens that result in periods of profound neutropenia leaving patients susceptible to severe infectious complications. Infectious complications are the leading cause of treatment related mortality among AML patients, but there are little clinical data to inform whether management of neutropenia post AML chemotherapy should occur in an outpatient or inpatient setting. The primary objective of this study is to compare the clinical effectiveness of outpatient versus inpatient management of neutropenia in children with AML.

Study identification

NCT ID
NCT02774850
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
610 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Up to 19 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2015
Primary completion
Jul 25, 2019
Completion
Jul 25, 2019
Last update posted
Dec 22, 2019

2015 – 2019

United States locations

U.S. sites
17
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
Lucile Packard Children's Hospital Palo Alto California 94304
Rady Children's Hospital San Diego California 92123
Children's Hospital of Colorado Aurora Colorado 80045
Alfred I DuPont Hospital for Children Wilmington Delaware 19803
Children's Healthcare of Atlanta Atlanta Georgia 30329
Ann & Robert H Lurie Children's Hospital Chicago Illinois 60611
Ochsner Medical Center New Orleans Louisiana 70121
Dana-Farber Cancer Institute/Boston Children's Hospital Boston Massachusetts 02215
C.S. Mott Children's Hospital Ann Arbor Michigan 48109
Children's Hospital of Michigan Detroit Michigan 48201
University of Mississippi Medical Center Jackson Mississippi 39216
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Children's Medical Center of Dallas Dallas Texas 75235
Texas Children's Hospital Houston Texas 77030
Primary Children's Hospital Salt Lake City Utah 84132
Seattle Children's Hospital Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02774850, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 22, 2019 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02774850 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →